ISRCTN01562001已完成未知
A Prospective, Randomised, Double-blind, Placebo Controlled Study to assess the Role of Aloe Vera with or without Glucosamine & Chondroitin in Patients with Symptomatic Osteoarthritis of Knees
Record Provided by the NHSTCT Register - 2007 Update - Department of Health0 个研究点目标入组 0 人开始时间: 2007年9月28日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age between 18 - 80 years
- •2. Symptoms of episodic or continuous pain in the affected knee joint for 6 weeks
- •3. Diagnosis of OA of Knee made according to ACR criteria (knee pain and radiographic osteophytes and at least any one of the following 3 items: a) Age > 50 years b) Morning Stiffness < 30 minutes in duration c) Crepitus on motion
排除标准
- •1. Any contra indication to Aloe Vera /Glucosamine/Chondroitin
- •2. Current Use or use within 3 months of screening of aloe vera/Glucosamine/Chondroitin
- •3. Current or Previous history of oral steroid or injection in the study joint within 3 months
- •4.Current or previous history of Intra articular Synvisc or Hyalgan therapy
- •5. Previous history of NSAID topical application within the last 3 months
- •6. Any previous history of Knee surgery including Menisectomy / patellectomy etc
- •7. Presence of Inflammatory Arthritis
- •8. Presence of significant hip disease on the side of symptomatic knee
研究者
相似试验
尚未招募
Unknown
Effect of GLUBLOC™ on blood glucose level after consumption of food among healthy individuals.CTRI/2023/07/055757Vidya Herbs Pvt Ltd
进行中（未招募）
1 期
A Prospective, Randomized, Double-blind, Placebo Controlled, Dose Ranging, Multi-Center Study of the Safety and Efficacy of Three Days Continuous Intravenous Infusion of GR270773 in the Treatment of Suspected or Confirmed Gram-negative Severe Sepsis in Adults. - LIPOSSuspected or Confirmed Gram-negative Severe Sepsis in AdultsEUCTR2004-000406-51-DKSepsicure LLC
进行中（未招募）
不适用
A Prospective, Randomized, Double-blind, Placebo Controlled, Dose Ranging, Multi-Center Study of the Safety and Efficacy of Three Days Continuous Intravenous Infusion of GR270773 in the Treatment of Suspected or Confirmed Gram-negative Severe Sepsis in Adults. - LIPOSEUCTR2004-000406-51-CZGlaxoSmithKline,s.r.o.1,890
进行中（未招募）
不适用
A Prospective, Randomized, Double-blind, Placebo Controlled, Dose Ranging, Multi-Center Study of the Safety and Efficacy of Three Days Continuous Intravenous Infusion of GR270773 in the Treatment of Suspected or Confirmed Gram-negative Severe Sepsis in Adults. - LIPOSSuspected or Confirmed Gram-negative Severe Sepsis in AdultsEUCTR2004-000406-51-HU1,890
进行中（未招募）
1 期
A Prospective, Randomized, Double-blind, Placebo Controlled, Dose Ranging, Multi-Center Study of the Safety and Efficacy of Three Days Continuous Intravenous Infusion of GR270773 in the Treatment of Suspected or Confirmed Gram-negative Severe Sepsis in Adults. - LIPOSEUCTR2004-000406-51-ESGlaxoSmithkline, S.A.